- Home
- ROIV vs BRBR Comparison
ROIV vs BRBR Comparison
Compare ROIV & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- BRBR
- Stock Information
- Founded
- ROIV 2014
- BRBR 2019
- Country
- ROIV United Kingdom
- BRBR United States
- Employees
- ROIV N/A
- BRBR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- BRBR Packaged Foods
- Sector
- ROIV Health Care
- BRBR Consumer Staples
- Exchange
- ROIV Nasdaq
- BRBR Nasdaq
- Market Cap
- ROIV 7.8B
- BRBR 7.3B
- IPO Year
- ROIV N/A
- BRBR 2019
- Fundamental
- Price
- ROIV $11.55
- BRBR $54.74
- Analyst Decision
- ROIV Buy
- BRBR Strong Buy
- Analyst Count
- ROIV 3
- BRBR 18
- Target Price
- ROIV $15.25
- BRBR $76.72
- AVG Volume (30 Days)
- ROIV 6.5M
- BRBR 2.5M
- Earning Date
- ROIV 08-07-2025
- BRBR 08-04-2025
- Dividend Yield
- ROIV N/A
- BRBR N/A
- EPS Growth
- ROIV N/A
- BRBR 49.75
- EPS
- ROIV N/A
- BRBR 2.14
- Revenue
- ROIV $29,053,000.00
- BRBR $2,192,100,000.00
- Revenue This Year
- ROIV $3.28
- BRBR $17.72
- Revenue Next Year
- ROIV $156.84
- BRBR $11.02
- P/E Ratio
- ROIV N/A
- BRBR $25.55
- Revenue Growth
- ROIV N/A
- BRBR 18.91
- 52 Week Low
- ROIV $8.73
- BRBR $48.06
- 52 Week High
- ROIV $13.06
- BRBR $80.67
- Technical
- Relative Strength Index (RSI)
- ROIV 55.27
- BRBR 37.24
- Support Level
- ROIV $11.31
- BRBR $53.57
- Resistance Level
- ROIV $11.64
- BRBR $59.10
- Average True Range (ATR)
- ROIV 0.29
- BRBR 1.61
- MACD
- ROIV 0.00
- BRBR -0.15
- Stochastic Oscillator
- ROIV 78.60
- BRBR 21.25
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channels including club, food, drug and mass, eCommerce, convenience and specialty.